ASTRAVEUS
Astraveus develops Lakhesys, the benchtop cell factory, a microfluidics based, automated and miniaturized cell and gene therapy production platform that aims at order of magnitude cost reduction through reduction of reagent, staff and infrastructure costs. Our objective is to enable patient access by facilitating the development of CGTs, from preclinical to commercial stages.
